The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Texas MPN Workshop 2022 | The need to improve diagnostic criteria in PV and other challenges in the field
Jerry Spivak, MD, Johns Hopkins University School of Medicine, Baltimore, MD, discusses unmet needs and challenges in polycythemia vera (PV), drawing focus on the high risk of thrombosis in patients. Prof. Spivak also comments on the need to improve diagnostic criteria for this disease, and highlights other factors that should be considered to improve the management and treatment of PV. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
